Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab is a research paper published in Prostate Cancer and Prostatic Diseases (2024). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →United States Department of Defense | U.S. Army
Grant: W81XWH-18-1-0278
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: U10CA180821
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: U10CA180822
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: U24CA196171
NCI NIH HHS
Grant: U10 CA180882
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: UG1 CA233180
NCI NIH HHS
Grant: UG1 CA233290
NCI NIH HHS
Grant: UG1 CA233341
NCI NIH HHS
Grant: UG1 CA233253
NCI NIH HHS
Grant: R01 CA155296
National Institutes of Health
Grant: 2U10CA180822-06
NRG Oncology - Statistical and Data Management Center
National Institutes of Health
Grant: 1UG1CA233253-01
NCI National Clinical Trials Network (UG1)
National Institutes of Health
Grant: 5R01CA256157-04
Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC
National Institutes of Health
Grant: 5UG1CA233341-05
Sidney Kimmel Cancer Center LAPS Institutional Collaboration
National Institutes of Health
Grant: 3U24CA196171-04S1
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
National Institutes of Health
Grant: 3U10CA180821-02S2
Alliance for Clinical Trials in Oncology Operations Center
National Institutes of Health
Grant: 5U10CA180882-02
Statistics and Data Center for the Alliance for Clinical Trials in Oncology
National Institutes of Health
Grant: 5UG1CA233180-02
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
Prostate Cancer Foundation
FWCI
0.83
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals